Technology Overview
CERVisure utilizes advanced AI-powered technology to analyze the genetic material of cervical cells. This involves evaluating the DNA ploidy, which is the number of sets of chromosomes in a cell. Abnormalities in DNA ploidy can indicate the presence of cancerous or pre-cancerous changes.
How It Works
The test examines the genetic stability of cells collected from the cervix. It looks for abnormalities that could suggest the presence of cervical cancer or the potential progression toward cancer. By assessing these genetic changes, CERVisure provides crucial information about a patient’s cervical health.
Test Procedure
The CERVisure test involves collecting a sample of cervical cells during a routine gynecological exam. The sample is then analyzed in a specialized laboratory where advanced algorithms assess the DNA ploidy and provide a detailed report on the findings.
Why This Test Matters?
CERVisure’s advanced technology and precise analysis offer a comprehensive understanding of cervical cell health, providing essential insights that guide effective prevention and treatment strategies. This test is a valuable tool for proactive cervical health management.